Targeted Oncology™ Adds The Florida Society of Clinical Oncology to Its Strategic Alliance Partnership Program
May 13, 2019
This partnership will also include sister platform The American
Journal of Managed Care®
CRANBURY, N.J.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/AJMC?src=hash" target="_blank"gt;#AJMClt;/agt;–Targeted Oncology™, a multimedia resource that offers content and
expert opinions on standard and emerging treatments in the oncology
field, announces the addition of The Florida Society of Clinical
Oncology (FLASCO) to its Strategic Alliance Partnership (SAP) program.
“We are proud to partner with The Florida Society of Clinical Oncology,”
said Michael J. Hennessy Jr., president of MJH Associates Inc., parent
company of Targeted Oncology™. “FLASCO works to transform the oncology
landscape and raise the standard of care in Florida.”
FLASCO is a member-supported oncology state society that focuses on
providing education, best practices and support to the over 3,300
oncology professionals it represents in Florida. FLASCO leads state
legislative efforts, champions cancer research and strives to advance
the future of oncology and champion patients with cancer in Florida.
Members represent integrated cancer care teams and include medical,
radiation, surgical, gynecologic, and pediatric oncologists; oncology
pharmacists; and oncologists in training, along with their teams that
include physician assistants, nurse practitioners, nurses, office
managers and other supporting staff who are currently serving in the
oncology field.
“The Florida Society of Clinical Oncology (FLASCO) is excited to partner
with MJH Associate Inc.,” said FLASCO President, Dr. Luis E Raez. “Their
experience in the oncology world that the SAP program is bringing,
facilitating exchange of medical information and increasing advocacy,
will benefit our patients and will aid in FLASCO’s continuous efforts to
be the Voice of Oncology in Florida.”
The SAP program is constantly building a community of advocacy groups,
medical associations and medical institutions to foster collaboration
and an open exchange of information for the ultimate benefit of patients
and their families and improving patient care. As part of this joint
effort, FLASCO will be working with Targeted Oncology™ along
with sister platform, The American Journal of Managed Care®
(AJMC®), to share exclusive digital content.
Recently AJMC® provided conference updates for FLASCO’s
Business of Oncology Summit Annual Meeting. The meeting increased
dialogue between physicians, patients, payers, pharmacists and
pharmaceutical representatives.
For more information about the Targeted Oncology™ SAP program, click here.
For more information about FLASCO, click here.
About Targeted Oncology™
TargetedOnc.com,
the online platform for Targeted Oncology™, provides the latest news and
insight on next-generation therapeutics and their molecular targets for
practicing oncologists. As the field of oncology continues to move
toward systemic biology and molecular aberrations, the challenge facing
many oncologists is to stay up-to-date with the future of cancer
therapeutics. As such, TargetedOnc.com strives to provide the latest
information on breaking news and updates on the burgeoning field.
TargetedOnc.com focuses on the next stage of cancer development and
cutting-edge therapies and their biological targets. Content is
organized by tumor type, news and conference coverage.
About The American Journal of Managed Care®
The
American Journal of Managed Care® (AJMC®)
is a multimedia peer-reviewed, Medline-indexed journal that keeps
industry leaders on the forefront of health policy by sharing digital
research relevant to industry decision-makers. Other brands in the AJMC®
family include The American Journal of Accountable Care®,Evidence-Based
Oncology™ and Evidence-Based Diabetes Management™. These
comprehensive multimedia brands bring together stakeholder views from
payers, providers, policymakers and other industry leaders in managed
care.
About The Florida Society of Clinical Oncology
The Florida Society of Clinical Oncology, which was formed in 1977, is a
statewide nonprofit 501©3 organization committed to facilitating and
promoting multidisciplinary efforts to improve patient care in Florida
by:
• Fostering access to quality cancer care to the citizens of Florida.
• Assisting cancer practitioners in providing the most cost-effective
quality care for their patients.
• Acting as an advocate for Florida patients with cancer and their
families.
• Coordinating the dissemination of information and providing an
opportunity for oncologists, physicians and other health care
professionals to network and exchange information.
Contacts
Targeted Oncology™ Media
Theresa Burek,
609-250-4331
[email protected]
John Patricolo, 609-325-4630
[email protected]
Targeted Oncology™ Adds The Florida Society of Clinical Oncology to Its Strategic Alliance Partnership Program
May 13, 2019
This partnership will also include sister platform The American
Journal of Managed Care®
CRANBURY, N.J.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/AJMC?src=hash" target="_blank"gt;#AJMClt;/agt;–Targeted Oncology™, a multimedia resource that offers content and
expert opinions on standard and emerging treatments in the oncology
field, announces the addition of The Florida Society of Clinical
Oncology (FLASCO) to its Strategic Alliance Partnership (SAP) program.
“We are proud to partner with The Florida Society of Clinical Oncology,”
said Michael J. Hennessy Jr., president of MJH Associates Inc., parent
company of Targeted Oncology™. “FLASCO works to transform the oncology
landscape and raise the standard of care in Florida.”
FLASCO is a member-supported oncology state society that focuses on
providing education, best practices and support to the over 3,300
oncology professionals it represents in Florida. FLASCO leads state
legislative efforts, champions cancer research and strives to advance
the future of oncology and champion patients with cancer in Florida.
Members represent integrated cancer care teams and include medical,
radiation, surgical, gynecologic, and pediatric oncologists; oncology
pharmacists; and oncologists in training, along with their teams that
include physician assistants, nurse practitioners, nurses, office
managers and other supporting staff who are currently serving in the
oncology field.
“The Florida Society of Clinical Oncology (FLASCO) is excited to partner
with MJH Associate Inc.,” said FLASCO President, Dr. Luis E Raez. “Their
experience in the oncology world that the SAP program is bringing,
facilitating exchange of medical information and increasing advocacy,
will benefit our patients and will aid in FLASCO’s continuous efforts to
be the Voice of Oncology in Florida.”
The SAP program is constantly building a community of advocacy groups,
medical associations and medical institutions to foster collaboration
and an open exchange of information for the ultimate benefit of patients
and their families and improving patient care. As part of this joint
effort, FLASCO will be working with Targeted Oncology™ along
with sister platform, The American Journal of Managed Care®
(AJMC®), to share exclusive digital content.
Recently AJMC® provided conference updates for FLASCO’s
Business of Oncology Summit Annual Meeting. The meeting increased
dialogue between physicians, patients, payers, pharmacists and
pharmaceutical representatives.
For more information about the Targeted Oncology™ SAP program, click here.
For more information about FLASCO, click here.
About Targeted Oncology™
TargetedOnc.com,
the online platform for Targeted Oncology™, provides the latest news and
insight on next-generation therapeutics and their molecular targets for
practicing oncologists. As the field of oncology continues to move
toward systemic biology and molecular aberrations, the challenge facing
many oncologists is to stay up-to-date with the future of cancer
therapeutics. As such, TargetedOnc.com strives to provide the latest
information on breaking news and updates on the burgeoning field.
TargetedOnc.com focuses on the next stage of cancer development and
cutting-edge therapies and their biological targets. Content is
organized by tumor type, news and conference coverage.
About The American Journal of Managed Care®
The
American Journal of Managed Care® (AJMC®)
is a multimedia peer-reviewed, Medline-indexed journal that keeps
industry leaders on the forefront of health policy by sharing digital
research relevant to industry decision-makers. Other brands in the AJMC®
family include The American Journal of Accountable Care®,Evidence-Based
Oncology™ and Evidence-Based Diabetes Management™. These
comprehensive multimedia brands bring together stakeholder views from
payers, providers, policymakers and other industry leaders in managed
care.
About The Florida Society of Clinical Oncology
The Florida Society of Clinical Oncology, which was formed in 1977, is a
statewide nonprofit 501©3 organization committed to facilitating and
promoting multidisciplinary efforts to improve patient care in Florida
by:
• Fostering access to quality cancer care to the citizens of Florida.
• Assisting cancer practitioners in providing the most cost-effective
quality care for their patients.
• Acting as an advocate for Florida patients with cancer and their
families.
• Coordinating the dissemination of information and providing an
opportunity for oncologists, physicians and other health care
professionals to network and exchange information.
Contacts
Targeted Oncology™ Media
Theresa Burek,
609-250-4331
[email protected]
John Patricolo, 609-325-4630
[email protected]